Collegium Pharmaceutical, Inc.

US$24.21As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:COLLHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 4.91%
Div yield —
ROE 13.36%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.73
PE TTM 21.38
TSR TTM (32.75%)
Mkt cap US$752.3M
ROIC 12.25%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$30
23.02%
(52.95%)
Hold 7|8|11|6|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.43
0.47
0.50
0.55
27.30%
35.50%
43.40%
42.09%
Revenue$M
67.27
69.60
72.01
75.43
5.06%
4.07%
4.52%
11.31%
Peers (US$752.3M)
Cap (US$)
PE
1.008B
—
752.8M
31.66x
Capital
TTM
5Y
10Y
Leveragex
2.921
0.939
1.097
EBIT/Intx
0.300
0.369
0.261
Own earn%
(43.79)
229.89
187.75
Sh yield%
35.59
40.58
41.50
Owners
Insiders/Inst%
2.94
81.99
Short interest%
4.74
SBC / revenue%
5.40
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
13–19
$1 testx
0.0
Incr. ROIC%
11